Minimal residual disease in Brazilian children with acute lymphoid leukemia: comparison of three detection methods by PCR

Leukemia Research
C A ScrideliL G Tone

Abstract

The minimal residual disease (MRD) detection by the polymerase chain reaction (PCR) in children with acute lymphoblastic leukemia has been pointed to be an adverse prognostic factor. Detection methods based on this technique using clone-specific primers are cumbersome and time consuming. The detection of monoclonal gene rearrangements of gamma T-cell receptors (TCRgamma) is a simpler although less sensitive method. In the present study, we analyzed the presence of MRD during four different phases of treatment (week 4; 3-6, 12-24 months, and end of treatment) in 34 Brazilian children with lymphoid leukemia by three detection methods based on the PCR technique: (1) using consensus primers for the detection of a clonal population for TCRgamma; (2) clone-specific primers for the junctional region of TCRgamma; and (3) a semi-nested reaction with an initial cycle with consensus primers followed by a second cycle with clone-specific primers. MRD presence was associated with a shorter event-free survival and was the major independent prognostic factor in most of the phases analyzed. The use of consensus primers for the detection of TCRgamma clonality, although less sensitive, proved to be a simpler, faster and less costly method whose ...Continue Reading

References

Dec 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R WassermanG Rovera
Apr 1, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·J J van Dongen, I L Wolvers-Tettero
Apr 14, 1983·Nature·S Tonegawa
Oct 1, 1994·Archives of Disease in Childhood·M B VianaW S Silvestrini
Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y ItoG Rovera
Jan 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Pinkel
Jan 30, 1997·The New England Journal of Medicine·W M RobertsT F Zipf
Jan 30, 1997·The New England Journal of Medicine·M Greaves
Jun 1, 1996·Cytokines and Molecular Therapy·J J van DongenH Hooijkaas
Jan 4, 1998·Journal of Pediatric Hematology/oncology·C A ScrideliL G Tone
Oct 28, 1999·Archives of Pathology & Laboratory Medicine·S FaderlZ Estrov
Nov 5, 1999·Current Opinion in Hematology·T Lion
Nov 28, 2001·São Paulo Medical Journal = Revista Paulista De Medicina·C A ScrideliL G Tone

❮ Previous
Next ❯

Citations

Jan 19, 2017·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·S BesbesZ Soua
Sep 10, 2003·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Carlos A ScrideliLuiz G Tone
Dec 6, 2006·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·J F MataL G Tone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.